Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.7K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
The Ras Gene02:38

The Ras Gene

7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Protein Modifications in the RER01:26

Protein Modifications in the RER

7.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
7.6K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

7.2K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.2K
Studying the Cytoskeleton01:17

Studying the Cytoskeleton

10.5K
The cytoskeletal architecture can be studied using different microscopic and biochemical techniques. Electron microscopy was instrumental in discovering the cytoskeletal architecture around the 1960s, which allowed obtaining structural information at a high-resolution level. However, the sample preparation procedure often limits this ability in biological samples. Several protocols have been developed over the years to optimize sample preparation. In one of the protocols known as rotary...
10.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of personality on likelihood of contracting SARS-CoV-2 in the United States.

Personality and individual differences·2026
Same author

Molecular dynamics and free energy analysis of curcumin binding near the DNA-recognition interface of NF-κB.

Scientific reports·2026
Same author

Integrating AI in Medicinal Chemistry for Accelerated Drug Discovery: A Comprehensive SAR (CSAR) Optimization Strategy and Discovery of Potent ALDH3A1 Inhibitors.

Journal of medicinal chemistry·2026
Same author

NF1 and SPRED1/2 cooperate through RAS-MAPK-independent functions.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Influence of Er:YAG Laser Dentin Conditioning with End-Firing Versus Side-Firing Tips on Human Dental Pulp-Derived Cell Viability.

Photobiomodulation, photomedicine, and laser surgery·2026
Same author

Conservative Management of Invasive Cervical Resorption Using Biodentine With Adjunctive Laser-Assisted Photodynamic and Photobiomodulation Therapy: A Case Report.

Cureus·2026

Related Experiment Video

Updated: Apr 1, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

6.2K

Disulfide tethering reveals cryptic pockets in oncogenic KRAS.

Trent E Balius1, Marcin Dyba1, Vandana Kumari1

  • 1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.

Communications Chemistry
|March 30, 2026
PubMed
Summary

Disulfide tethering successfully identified novel binding pockets on oncogenic KRAS (Kirsten rat sarcoma viral oncogene homolog). This drug discovery approach revealed druggable "hot spots" for targeting this previously undruggable cancer-associated protein.

More Related Videos

Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
09:37

Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture

Published on: May 2, 2019

10.9K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.8K

Related Experiment Videos

Last Updated: Apr 1, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

6.2K
Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
09:37

Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture

Published on: May 2, 2019

10.9K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.8K

Area of Science:

  • Oncology
  • Chemical Biology
  • Structural Biology

Background:

  • Oncogenic KRAS is a challenging cancer target due to high nucleotide affinity.
  • Disulfide tethering is a fragment-based drug discovery method for difficult targets.
  • KRAS G12D is a common oncogenic mutation in various cancers.

Purpose of the Study:

  • To apply disulfide tethering to identify novel ligands and binding sites on oncogenic KRAS.
  • To explore the druggability of KRAS by mapping potential ligand-binding pockets.
  • To validate identified hits using biophysical and computational methods.

Main Methods:

  • Screening a library of 2160 disulfide-containing fragments against 83 engineered KRAS G12D cysteine mutants.
  • Performing 2-mercaptoethanol competition assays (βME-50) to prioritize ligands.
  • Utilizing computational chemistry and NMR spectroscopy for hit validation.

Main Results:

  • Identification of known KRAS binding sites, including the Switch-II / α-helix 3 pocket.
  • Discovery of previously undescribed cryptic pockets on KRAS.
  • Validation of select fragment hits, confirming their interaction with identified pockets.

Conclusions:

  • Disulfide tethering is effective for discovering ligands against challenging targets like KRAS.
  • Identified cryptic pockets represent promising new opportunities for KRAS-targeted drug discovery.
  • This approach enhances the understanding of KRAS ligandability and druggable regions.